KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) Equity Income: 2009-2024

Historic Equity Income for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $350.9 million.

  • Cme Group's Equity Income rose 11.85% to $96.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $374.7 million, marking a year-over-year increase of 14.76%. This contributed to the annual value of $350.9 million for FY2024, which is 18.19% up from last year.
  • As of FY2024, Cme Group's Equity Income stood at $350.9 million, which was up 18.19% from $296.9 million recorded in FY2023.
  • In the past 5 years, Cme Group's Equity Income ranged from a high of $350.9 million in FY2024 and a low of $190.6 million during FY2020.
  • For the 3-year period, Cme Group's Equity Income averaged around $316.3 million, with its median value being $301.1 million (2022).
  • As far as peak fluctuations go, Cme Group's Equity Income rose by 28.96% in 2021, and later decreased by 1.39% in 2023.
  • Yearly analysis of 5 years shows Cme Group's Equity Income stood at $190.6 million in 2020, then climbed by 28.96% to $245.8 million in 2021, then increased by 22.50% to $301.1 million in 2022, then declined by 1.39% to $296.9 million in 2023, then grew by 18.19% to $350.9 million in 2024.